Benchmarking of protein descriptor sets in proteochemometric modeling (part 2): modeling performance of 13 amino acid descriptor sets
暂无分享,去创建一个
Isidro Cortes-Ciriano | Gerard J. P. van Westen | John P. Overington | Jörg K. Wegner | Adriaan P. IJzerman | Andreas Bender | Herman van Vlijmen | Remco F. Swier | A. Bender | J. Wegner | A. IJzerman | I. Cortés-Ciriano | G. V. Westen | H. Vlijmen | G. Westen
[1] Andrea Zaliani,et al. MS-WHIM Scores for Amino Acids: A New 3D-Description for Peptide QSAR and QSPR Studies , 1999, J. Chem. Inf. Comput. Sci..
[2] Dong-Sheng Cao,et al. propy: a tool to generate various modes of Chou's PseAAC , 2013, Bioinform..
[3] S. Wold,et al. Minimum analogue peptide sets (MAPS) for quantitative structure-activity relationships. , 2009, International journal of peptide and protein research.
[4] Charlotte M. Deane,et al. JOY: protein sequence-structure representation and analysis , 1998, Bioinform..
[5] T. Lundstedt,et al. Development of proteo-chemometrics: a novel technology for the analysis of drug-receptor interactions. , 2001, Biochimica et biophysica acta.
[6] Gerard J. P. van Westen,et al. Proteochemometric modeling as a tool to design selective compounds and for extrapolating to novel targets , 2011 .
[7] D. Richman,et al. 2022 update of the drug resistance mutations in HIV-1. , 2022, Topics in antiviral medicine.
[8] S Wold,et al. Quantitative sequence-activity models (QSAM)--tools for sequence design. , 1993, Nucleic acids research.
[9] Zhiliang Li,et al. Factor Analysis Scale of Generalized Amino Acid Information as the Source of a New Set of Descriptors for Elucidating the Structure and Activity Relationships of Cationic Antimicrobial Peptides , 2007 .
[10] J. Komorowski,et al. Proteochemometrics mapping of the interaction space for retroviral proteases and their substrates. , 2009, Bioorganic & medicinal chemistry.
[11] Pierre Baldi,et al. Assessing the accuracy of prediction algorithms for classification: an overview , 2000, Bioinform..
[12] Kathrin Heikamp,et al. Comparison of Confirmed Inactive and Randomly Selected Compounds as Negative Training Examples in Support Vector Machine-Based Virtual Screening , 2013, J. Chem. Inf. Model..
[13] W. Dunn,et al. Amino acid side chain descriptors for quantitative structure-activity relationship studies of peptide analogues. , 1995, Journal of medicinal chemistry.
[14] Peng Zhou,et al. Gaussian process: an alternative approach for QSAM modeling of peptides , 2008, Amino Acids.
[15] Jarl E. S. Wikberg,et al. Proteochemometric Modeling of Drug Resistance over the Mutational Space for Multiple HIV Protease Variants and Multiple Protease Inhibitors , 2009, J. Chem. Inf. Model..
[16] Jarl E. S. Wikberg,et al. Interaction Model Based on Local Protein Substructures Generalizes to the Entire Structural Enzyme-Ligand Space , 2008, J. Chem. Inf. Model..
[17] H. V. van Vlijmen,et al. Which Compound to Select in Lead Optimization? Prospectively Validated Proteochemometric Models Guide Preclinical Development , 2011, PloS one.
[18] Andreas Bender,et al. Handbook of Chemoinformatics Algorithms , 2010 .
[19] Didier Rognan,et al. Protein-Ligand-Based Pharmacophores: Generation and Utility Assessment in Computational Ligand Profiling , 2012, J. Chem. Inf. Model..
[20] Michael J. Keiser,et al. Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.
[21] P. Prusis,et al. Melanocortin Receptors: Ligands and Proteochemometrics Modeling , 2003, Annals of the New York Academy of Sciences.
[22] Jean-Philippe Vert,et al. Virtual screening of GPCRs: An in silico chemogenomics approach , 2008, BMC Bioinformatics.
[23] R. Leurs,et al. A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design , 2013, British journal of pharmacology.
[24] A. Tropsha,et al. Predictive quantitative structure-activity relationship modeling , 2007 .
[25] S. Wold,et al. New chemical descriptors relevant for the design of biologically active peptides. A multivariate characterization of 87 amino acids. , 1998, Journal of medicinal chemistry.
[26] John P. Overington,et al. Chemogenomics approaches for receptor deorphanization and extensions of the chemogenomics concept to phenotypic space. , 2011, Current topics in medicinal chemistry.
[27] Shengshi Z. Li,et al. A new set of amino acid descriptors and its application in peptide QSARs. , 2005, Biopolymers.
[28] Andy Liaw,et al. Classification and Regression by randomForest , 2007 .
[29] Brian T. Foley,et al. Numbering Positions in HIV Relative to HXB 2 CG , 1999 .
[30] Andreas Bender,et al. How Similar Are Similarity Searching Methods? A Principal Component Analysis of Molecular Descriptor Space , 2009, J. Chem. Inf. Model..
[31] Peteris Prusis,et al. Prediction of indirect interactions in proteins , 2006, BMC Bioinformatics.
[32] R. Shafer,et al. Update of the drug resistance mutations in HIV-1: March 2013. , 2013, Topics in antiviral medicine.
[33] Alexander G. Georgiev,et al. Interpretable Numerical Descriptors of Amino Acid Space , 2009, J. Comput. Biol..
[34] Peteris Prusis,et al. Proteochemometric modeling of HIV protease susceptibility , 2008, BMC Bioinformatics.
[35] B. Matthews. Comparison of the predicted and observed secondary structure of T4 phage lysozyme. , 1975, Biochimica et biophysica acta.
[36] T. Lundstedt,et al. Proteochemometrics modeling of the interaction of amine G-protein coupled receptors with a diverse set of ligands. , 2002, Molecular pharmacology.
[37] L. Jiang,et al. PROFEAT: a web server for computing structural and physicochemical features of proteins and peptides from amino acid sequence , 2006, Nucleic Acids Res..
[38] Gerard J. P. van Westen,et al. Significantly Improved HIV Inhibitor Efficacy Prediction Employing Proteochemometric Models Generated From Antivirogram Data , 2013, PLoS Comput. Biol..
[39] Z. R. Li,et al. Update of PROFEAT: a web server for computing structural and physicochemical features of proteins and peptides from amino acid sequence , 2006, Nucleic Acids Res..
[40] Jarl E. S. Wikberg,et al. Kinome-wide interaction modelling using alignment-based and alignment-independent approaches for kinase description and linear and non-linear data analysis techniques , 2010, BMC Bioinformatics.
[41] F. Tian,et al. T-scale as a novel vector of topological descriptors for amino acids and its application in QSARs of peptides , 2007 .
[42] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[43] G. V. van Westen,et al. Structure-Based Identification of OATP1B1/3 Inhibitors , 2013, Molecular Pharmacology.
[44] John P. Overington,et al. A ligand's-eye view of protein similarity , 2013, Nature Methods.
[45] Dong-Sheng Cao,et al. Genome-Scale Screening of Drug-Target Associations Relevant to Ki Using a Chemogenomics Approach , 2013, PloS one.
[46] Andreas Bender,et al. Mining protein dynamics from sets of crystal structures using “consensus structures” , 2010, Protein science : a publication of the Protein Society.
[47] H. V. van Vlijmen,et al. Identifying novel adenosine receptor ligands by simultaneous proteochemometric modeling of rat and human bioactivity data. , 2012, Journal of medicinal chemistry.
[48] Evi Kostenis,et al. A physicogenetic method to assign ligand-binding relationships between 7TM receptors. , 2005, Bioorganic & medicinal chemistry letters.
[49] John P. Overington,et al. ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..
[50] H. Carlson. Protein flexibility and drug design: how to hit a moving target. , 2002, Current opinion in chemical biology.
[51] K. Fidelis,et al. Generalized modeling of enzyme–ligand interactions using proteochemometrics and local protein substructures , 2006, Proteins.
[52] Didier Rognan,et al. A chemogenomic analysis of the transmembrane binding cavity of human G‐protein‐coupled receptors , 2005, Proteins.
[53] David Rogers,et al. Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..
[54] F. Wilcoxon. Individual Comparisons by Ranking Methods , 1945 .
[55] S. Wold,et al. Peptide quantitative structure-activity relationships, a multivariate approach. , 1987, Journal of medicinal chemistry.
[56] Nathanael Weill,et al. Development and Validation of a Novel Protein-Ligand Fingerprint To Mine Chemogenomic Space: Application to G Protein-Coupled Receptors and Their Ligands , 2009, J. Chem. Inf. Model..
[57] Michael T. M. Emmerich,et al. A novel chemogenomics analysis of G protein-coupled receptors (GPCRs) and their ligands: a potential strategy for receptor de-orphanization , 2010, BMC Bioinformatics.
[58] Peteris Prusis,et al. A Look Inside HIV Resistance through Retroviral Protease Interaction Maps , 2007, PLoS Comput. Biol..
[59] Gert Vriend,et al. GPCRDB information system for G protein-coupled receptors , 2003, Nucleic Acids Res..
[60] Robert D Clark,et al. Neighborhood behavior: a useful concept for validation of "molecular diversity" descriptors. , 1996, Journal of medicinal chemistry.
[61] David A. Gough,et al. Virtual Screen for Ligands of Orphan G Protein-Coupled Receptors , 2005, J. Chem. Inf. Model..
[62] M. Shu,et al. ST-scale as a novel amino acid descriptor and its application in QSAM of peptides and analogues , 2010, Amino Acids.
[63] Saskia Nijmeijer,et al. Small and colorful stones make beautiful mosaics: fragment-based chemogenomics. , 2013, Drug Discovery Today.
[64] Gerard J. P. van Westen,et al. Benchmarking of protein descriptor sets in proteochemometric modeling (part 1): comparative study of 13 amino acid descriptor sets , 2013, Journal of Cheminformatics.